Loading compare…
4 funds hold both · as on May 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 4 mutual funds hold active equity positions in both Rossari Biotech and Reliance Industries. The scheme with the highest combined exposure is UTI Multi Cap Fund (UTI MF), which holds a 0.53% stake in Rossari Biotech and a 2.30% stake in Reliance Industries, amounting to a combined conviction weight of 2.83%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Rossari wt. | Reliance wt. | Combined |
|---|---|---|---|
| UTI Multi Cap FundUTI MF · Multi Cap | 0.53% | 2.30% | |
| UTI Aggressive Hybrid FundUTI MF · Hybrid | 0.29% | 2.49% | |
| UTI Large & Mid Cap FundUTI MF · Large & Mid Cap | 0.33% | 2.17% | |
| UTI Retirement FundUTI MF · Solution-Oriented | 0.16% | 1.42% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on May 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.